Our immune globulin product portfolio
With three FDA-approved products, the mission of ADMA Biologics is to continue to successfully commercialize plasma-derived, human immune globulins targeted to specific patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations.
Our dedicated patient support hub helps simplify access to ASCENIV™ and BIVIGAM®
Can help eligible patients:
- Maximize insurance benefits and minimize overall treatment costs
- Locate alternative funding and other payment options, such as nonprofit patient assistance foundations
Supports providers and staff with:
- Benefits verification to determine coverage, including out-of-pocket costs, and payer requirements
- Claims, reimbursement support, and appeals
ADMA is committed to helping patients with access to their therapy. If you need additional information on financial assistance or resources, the National Organization for Rare Disorders (NORD) may be able to assist.